GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 717 filers reported holding GLAXOSMITHKLINE PLC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $153,000 | -5.6% | 3,975 | +1.9% | 0.01% | 0.0% |
| Q2 2015 | $162,000 | +6.6% | 3,900 | +18.8% | 0.01% | +11.1% |
| Q1 2015 | $152,000 | +4.1% | 3,283 | -4.0% | 0.01% | 0.0% |
| Q4 2014 | $146,000 | +2.1% | 3,419 | +10.2% | 0.01% | -10.0% |
| Q3 2014 | $143,000 | -4.7% | 3,102 | +10.7% | 0.01% | -9.1% |
| Q2 2014 | $150,000 | +0.7% | 2,803 | +0.4% | 0.01% | -8.3% |
| Q1 2014 | $149,000 | -2.0% | 2,793 | -1.8% | 0.01% | 0.0% |
| Q4 2013 | $152,000 | +2.7% | 2,844 | -3.5% | 0.01% | -14.3% |
| Q3 2013 | $148,000 | -3.9% | 2,946 | -4.1% | 0.01% | -12.5% |
| Q2 2013 | $154,000 | -12.5% | 3,073 | -18.1% | 0.02% | -15.8% |
| Q1 2013 | $176,000 | -26.4% | 3,750 | -29.2% | 0.02% | -40.6% |
| Q2 2012 | $239,000 | -11.5% | 5,300 | -11.7% | 0.03% | -3.0% |
| Q1 2012 | $270,000 | +5.5% | 6,000 | +7.1% | 0.03% | -2.9% |
| Q4 2011 | $256,000 | -32.1% | 5,600 | -38.0% | 0.03% | -39.3% |
| Q3 2011 | $377,000 | – | 9,027 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |